Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Aug 5, 2010


Tolerx announced that it has appointed Antonin de Fougerolles as its new CSO.

De Fougerolles previously served as vice president of research, immunology, and metabolic and viral diseases at Alnylam Pharmaceuticals. Prior to that, he was a principal scientist at Biogen.